ロード中...

Clinical laboratory experience of blood CRIM testing in infantile Pompe disease

Cross-reactive immunological material (CRIM) status is an important prognostic factor in patients with infantile Pompe disease (IPD) being treated with enzyme replacement therapy. Western blot analysis of cultured skin fibroblast lysates has been the gold standard for determining CRIM status. Here,...

詳細記述

保存先:
書誌詳細
出版年:Mol Genet Metab Rep
主要な著者: Bali, Deeksha S., Goldstein, Jennifer L., Rehder, Catherine, Kazi, Zoheb B., Berrier, Kathryn L., Dai, Jian, Kishnani, Priya S.
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674832/
https://ncbi.nlm.nih.gov/pubmed/26693141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgmr.2015.10.012
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!